Follow
Adam Hogendorf
Adam Hogendorf
Department of Medicinal Chemistry, University of Utah
Verified email at if-pan.krakow.pl - Homepage
Title
Cited by
Cited by
Year
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
J Staroń, R Kurczab, D Warszycki, G Satała, M Krawczyk, R Bugno, ...
European Journal of Medicinal Chemistry 185, 111857, 2020
312020
Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1 H-imidazol-5-yl)-1 H-indole-5-carboxamides, low-basicity 5-HT 7 …
G Latacz, AS Hogendorf, A Hogendorf, A Lubelska, JM Wierońska, ...
MedChemComm 9 (11), 1882-1890, 2018
302018
Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behavior
M Bijata, E Bączyńska, FE Müller, K Bijata, J Masternak, A Krzystyniak, ...
Cell Reports 38 (11), 2022
282022
Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents
T Stefański, R Mikstacka, R Kurczab, Z Dutkiewicz, M Kucińska, M Murias, ...
European journal of medicinal chemistry 144, 797-816, 2018
262018
2-Aminoimidazole-based antagonists of the 5-HT6 receptor–A new concept in aminergic GPCR ligand design
AS Hogendorf, A Hogendorf, R Kurczab, J Kalinowska-Tłuścik, P Popik, ...
European Journal of Medicinal Chemistry 179, 1-15, 2019
252019
Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers
AS Hogendorf, A Hogendorf, K Popiołek-Barczyk, A Ciechanowska, ...
European Journal of Medicinal Chemistry 170, 261-275, 2019
252019
5-HT1A receptor ligands and their therapeutic applications: review of new patents
J Staroń, R Bugno, AS Hogendorf, AJ Bojarski
Expert Opinion on Therapeutic Patents 28 (9), 679-689, 2018
252018
Regioselective hydroxylation of cholecalciferol, cholesterol and other sterol derivatives by steroid C25 dehydrogenase
A Rugor, M Tataruch, J Staroń, A Dudzik, E Niedzialkowska, P Nowak, ...
Applied microbiology and biotechnology 101, 1163-1174, 2017
212017
Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol
AS Hogendorf, A Hogendorf, R Kurczab, G Satała, T Lenda, M Walczak, ...
Scientific Reports 7 (1), 1444, 2017
192017
Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats
P Popik, A Hogendorf, R Bugno, SYS Khoo, P Zajdel, ...
Psychopharmacology 239 (6), 1689-1703, 2022
162022
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands–Fluoxetine and fluvoxamine
J Staroń, W Pietruś, R Bugno, R Kurczab, G Satała, D Warszycki, T Lenda, ...
European Journal of Medicinal Chemistry 220, 113533, 2021
162021
Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats
P Popik, SYS Khoo, A Kuziak, J Golebiowska, A Potasiewicz, ...
Pharmacology Biochemistry and Behavior 197, 173011, 2020
112020
Pyrano[2,3,4-cd]indole as a Scaffold for Selective Nonbasic 5-HT6R Ligands
J Staroń, S Mordalski, D Warszycki, G Satała, A Hogendorf, AJ Bojarski
ACS Medicinal Chemistry Letters 8 (4), 390-394, 2017
102017
The effect of the intramolecular C–H⋯ O interactions on the conformational preferences of bis-arylsulfones–5-HT 6 receptor antagonists and beyond
J Kalinowska-Tłuścik, J Staroń, A Krawczuk, S Mordalski, D Warszycki, ...
RSC advances 8 (33), 18672-18681, 2018
82018
How can fluorine directly and indirectly affect the hydrogen bonding in molecular systems?–A case study for monofluoroanilines
W Pietruś, R Kurczab, R Kafel, E Machalska, J Kalinowska-Tłuścik, ...
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 252, 119536, 2021
62021
Halogen bonding enhances activity in a series of dual 5-HT 6/D 2 ligands designed in a hybrid bioisostere generation/virtual screening protocol
J Staroń, D Warszycki, R Kurczab, G Satała, R Bugno, A Hogendorf, ...
RSC advances 6 (60), 54918-54925, 2016
62016
Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties
K Kaczorowska, A Stankiewicz, R Bugno, MH Paluchowska, G Burnat, ...
International Journal of Molecular Sciences 24 (3), 1981, 2023
52023
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats
P Popik, M Krawczyk, A Kuziak, R Bugno, A Hogendorf, J Staroń, ...
Journal of Psychopharmacology 33 (11), 1447-1455, 2019
52019
N-Skatyltryptamines—Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive Potential
A Hogendorf, AS Hogendorf, R Kurczab, G Satała, B Szewczyk, P Cieślik, ...
Molecules 26 (15), 4605, 2021
32021
The effect of the intramolecular CH center dot center dot center dot O interactions on the conformational preferences of bis-arylsulfones-5-HT6 receptor antagonists and beyond
J Kalinowska-Tluscik, J Staron, A Krawczuk, S Mordalski, D Warszycki, ...
RSC ADVANCES 8 (33), 18672-18681, 2018
32018
The system can't perform the operation now. Try again later.
Articles 1–20